Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05354557
What this trial is testing

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 16
Not applicableStudy completedNCT03197428
What this trial is testing

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Who this might be right for
Ankle InstabilityPlatelet-rich Plasma
Pei-Yuan Lee, MD 20
Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Post-approval studies (Phase 4)Looking for participantsNCT05726136
What this trial is testing

Fluid Challenge and Plasma Volume, During Surgery

Who this might be right for
Colorectal CancerUrologic CancerGynecologic Cancer+2 more
Joachim Zdolsek 60
Post-approval studies (Phase 4)Ended earlyNCT05205837
What this trial is testing

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Who this might be right for
HypogonadismHypogonadism, MaleHypogonadotropic Hypogonadism
Rigshospitalet, Denmark 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05177536
What this trial is testing

Iberdomide Maintenance Therapy in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Nebraska 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070934
What this trial is testing

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

Who this might be right for
Multiple MyelomaNewly Diagnosed
Xuzhou Medical University 60
Not applicableStudy completedNCT04409314
What this trial is testing

Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Recurrent Aggressive Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+9 more
University of California, San Francisco 23
Early research (Phase 1)Study completedNCT04554992
What this trial is testing

Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

Who this might be right for
Covid19
The Methodist Hospital Research Institute 350
Not applicableLooking for participantsNCT05245136
What this trial is testing

Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.

Who this might be right for
Characteristics DiseaseMetastatic CancerSolid Tumor
University Hospital Augsburg 3,000
Large-scale testing (Phase 3)WithdrawnNCT02155634
What this trial is testing

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsPlasma Cells+4 more
Celgene
Testing effectiveness (Phase 2)Study completedNCT00003399
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Post-approval studies (Phase 4)Study completedNCT00741663
What this trial is testing

Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)

Who this might be right for
CirrhosisAscites
University of Padova 100
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Not applicableLooking for participantsNCT07565844
What this trial is testing

Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia

Who this might be right for
Postherpetic Neuralgia ( PHN )
Zagazig University 45
Testing effectiveness (Phase 2)Study completedNCT00532844
What this trial is testing

A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction

Who this might be right for
Endothelial Dysfunction
BioMarin Pharmaceutical 52
Large-scale testing (Phase 3)Study completedNCT01311687
What this trial is testing

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study

Who this might be right for
Multiple Myeloma
Celgene 455
Testing effectiveness (Phase 2)Ended earlyNCT01548573
What this trial is testing

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
University of Iowa 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04656951
What this trial is testing

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Who this might be right for
Multiple Myeloma
University of Cologne 67
Next Page